Results 321 to 330 of about 60,427 (345)
Some of the next articles are maybe not open access.
COVID-19 drugs and drug repositioning
2021Introduction: The COVID-19 pandemic is caused by SARS-CoV-2. Drug repositioning is a propitious field in the development and discovery of therapeutic agents that distinguishes new therapeutic options for existing drugs. There are repositioned drugs in COVID-19 treatment. Aim: We aimed to explore repositioned drugs for COVID-19 pharmacotherapy.
openaire +1 more source
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Biomedical data and computational models for drug repositioning: a comprehensive review
Briefings in Bioinformatics, 2021Huimin Luo, Gaoshi Li, Mengyun Yang
exaly
Structure-based drug repositioning: Potential and limits
Seminars in Cancer Biology, 2021Melissa F Adasme +2 more
exaly
Deep learning in target prediction and drug repositioning: Recent advances and challenges
Drug Discovery Today, 2022Guo-Bo Li
exaly
Drug repositioning: Progress and challenges in drug discovery for various diseases
European Journal of Medicinal Chemistry, 2022Ya-Dong Chen, Yanmin Zhang
exaly
Drug repositioning based on the heterogeneous information fusion graph convolutional network
Briefings in Bioinformatics, 2021Changcheng Lu, Yajie Meng, Peng Wang
exaly